Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria

International Journal of STD and AIDS

Volumn 20, Issue 6, 2009, Pages 410-413

  Agaba, Patricia A ^a   Sule, H M ^a   Ojoh, R O ^a   Hassan, Z ^a   Apena, L ^a   Mu'Azu, M A ^a   Badung, B ^a   Agbaji, O O ^a   Idoko, J A ^a   Kanki, P ^b  

^a UNIVERSITY OF JOS   (Nigeria)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS related Kaposi's sarcoma; Nigeria; Survival

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NIGERIA; PRIORITY JOURNAL; SURVIVAL; TUBERCULOSIS; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; NIGERIA; SARCOMA, KAPOSI; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 67549130451     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008353     Document Type: Article

References (23)

1. Sanders CJG, Canninga-van Djik MR, Borleffs JC. Kaposi's sarcoma. Lancet 2004;364:1549-1552 (Pubitemid 39410423)
2. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000;342:27-38 (Pubitemid 30180651)
3. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869
4. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002;94:1204-1210
5. Banda LT, Parkin DM, Dzamalala CP, Liomba NG. Cancer incidence in Blantyre, Malawi 1994-1998. Trop Med Int Health 2001;6:296-304
6. Chokunonga E, Levy LM, Bassett MT, Mauchaza BG, Thomas DB, Parkin DM. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer 2000;85:54-59
7. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000;82:1585-1592
8. Ziegler JL, Newton R, Katongole-Mbidde E, et al. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS 1997;11:1619-1626 (Pubitemid 27460252)
9. Sitas F, Carrara H, Beral V, et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999;340:1863-1871 (Pubitemid 29272666)
10. Kagu MB, Ngadda HA, Garandawa HI, Askira BH, Durosinmi MA. AIDS-associated Kaposi's sarcoma in north-eastern Nigeria. Singapore Med J 2006;47:1069-1074 (Pubitemid 44901383)
11. Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma associated herpes virus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 2003;88:1-3 (Pubitemid 36241209)
12. Nasti G, Serraino D, Ridolfo A, et al. AIDS-associated Kaposi's sarcoma is more aggressive in women: a study of 54 patients. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:337-341 (Pubitemid 29143027)
13. Nnoruka EN. Epidemic (human immunodeficiency virus-related) Kaposi's sarcoma in West African women. Int J Dermatol 2003;42:794-799
14. Eltom MA, Jemal A, Mbulaiteye SM, et al. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Can Inst 2002;94:1204-1210
15. Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, et al. The changing pattern of Kaposi's sarcoma in patients with HIV, 1994-2003: the EuroSIDA study. Cancer 2004;100:2644-2654
16. Onunu AN, Okoduwa C, Eze EU, Adeyekun AA, Kubeyinje EP, Schwartz RA. Kaposi's sarcoma in Nigeria. Int J Dermatol 2007;46:264-267 (Pubitemid 46390282)
17. Onyango JF, Njiru A. Kaposi's sarcoma in a Nairobi Hospital. East Afr Med J 2004;81:120-123
18. Mohammed AZ, Nwana EJC, Manasseh AN. Changing patterns of Kaposi sarcoma in Nigerians. Trop Doc 2005;35:168-169 (Pubitemid 41192192)
19. Dezube BJ. The role of human immunodeficiency virus-1 in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu. Semin Oncol 2000;27:420-423 (Pubitemid 30626440)
20. Tam HK, Zhang ZF, Jacobson LP, et al. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 2002;98:916-922 (Pubitemid 34286691)
21. Stebbing J, Mmazhar D, Lewis R, et al. The presentation and survival of patients with non-cutaneous AIDS-related Kaposi's sarcoma. Ann Oncol 2006;17:503-506 (Pubitemid 43329590)
22. Krown SE, Testa MA, Huang J. AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 1997;15:3085-3092
23. Nasti G, Talamini R, Antinori A, et al. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era-the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals. J Clin Oncol 2003;21:2876-2882 (Pubitemid 46621836)